Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.


Arslan D., Tural D., KOCA T., TAŞTEKİN D., CERKESLI A. K., BASARAN H., ...More

Journal of B.U.ON. : official journal of the Balkan Union of Oncology, vol.20, no.2, pp.573-9, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 2
  • Publication Date: 2015
  • Journal Name: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.573-9
  • Keywords: clinical stage T4N2, locally advanced non-small cell lung cancer, patient outcome, prognostic factors, treatment modality, survival, SOUTHWEST-ONCOLOGY-GROUP, PHASE-II, INDUCTION CHEMOTHERAPY, POOLED ANALYSIS, CONCURRENT, RADIOTHERAPY, SURVIVAL, CHEMORADIOTHERAPY, PACLITAXEL, CISPLATIN
  • Akdeniz University Affiliated: Yes

Abstract

Purpose: Relatively few studies have focused on T4N2 (stage IIIB) locally advanced non-small cell lung cancer (NSCLC). In this study, we tried to identify prognostic factors for patients with clinical stage T4N2 NSCLC.